- This event has passed.
Introduction to Ra Pharma & the Potential of Zilucoplan for the Treatment of IMNM
November 6 @ 7:00 pm - 8:00 pm EST
Wednesday, November 6, 2019
7:00 PM Eastern
Register to attend
Click the button below to register for this live webinar. Registration is required.
You will receive an email with the information needed to join.
Ben Matys, Sr. Clinical Trial Manager, and Ramin Farzaneh-Far, Chief Medical Officer of Ra Pharma, will join MSU on Wednesday, November 6, 2019, at 7 PM Eastern time, for a live webinar, “Introduction to Ra Pharma & the Potential of Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy (IMNM)”
There will also be live Q&A at the end. This session will be recorded.
Learn more about Ra Pharma’s Phase 2 Study of Zilucoplan in Patients with Immune-Mediated Necrotizing Myopathy.